HCA Healthcare Inc (HCA) CMO Sells $3,926,884.00 in Stock

HCA Healthcare Inc (NYSE:HCA) CMO Jonathan B. Perlin sold 38,480 shares of the business’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $102.05, for a total transaction of $3,926,884.00. Following the sale, the chief marketing officer now owns 119,778 shares of the company’s stock, valued at approximately $12,223,344.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

HCA Healthcare Inc (NYSE:HCA) opened at $101.00 on Wednesday. HCA Healthcare Inc has a 1-year low of $71.18 and a 1-year high of $106.84. The stock has a market cap of $35,760.00, a price-to-earnings ratio of 19.77, a PEG ratio of 1.01 and a beta of 0.48. The company has a current ratio of 1.62, a quick ratio of 1.36 and a debt-to-equity ratio of -6.58.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, January 30th. The company reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.25. HCA Healthcare had a net margin of 4.89% and a negative return on equity of 49.49%. The company had revenue of $11.56 billion during the quarter, compared to the consensus estimate of $11.19 billion. During the same quarter in the previous year, the company posted $1.80 earnings per share. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. sell-side analysts expect that HCA Healthcare Inc will post 8.71 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Thursday, March 1st will be issued a dividend of $0.35 per share. This represents a $1.40 annualized dividend and a dividend yield of 1.39%. The ex-dividend date of this dividend is Wednesday, February 28th.

Several research firms have weighed in on HCA. Argus set a $97.00 target price on shares of HCA Healthcare and gave the company a “buy” rating in a research note on Wednesday, January 10th. Piper Jaffray Companies reiterated a “hold” rating and set a $101.00 target price on shares of HCA Healthcare in a research note on Tuesday, January 30th. Sanford C. Bernstein reiterated a “market perform” rating and set a $116.00 target price (up previously from $105.00) on shares of HCA Healthcare in a research note on Thursday, February 1st. ValuEngine upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, November 30th. Finally, BMO Capital Markets boosted their target price on shares of HCA Healthcare from $96.00 to $115.00 and gave the company an “outperform” rating in a research note on Thursday, February 1st. They noted that the move was a valuation call. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have assigned a buy rating to the company. HCA Healthcare currently has an average rating of “Buy” and a consensus target price of $104.50.

Institutional investors and hedge funds have recently made changes to their positions in the company. Magellan Asset Management Ltd lifted its holdings in HCA Healthcare by 39.1% in the fourth quarter. Magellan Asset Management Ltd now owns 16,660,349 shares of the company’s stock worth $1,463,445,000 after purchasing an additional 4,681,672 shares during the period. Lyrical Asset Management LP acquired a new stake in HCA Healthcare in the fourth quarter worth about $324,051,000. Longview Partners Guernsey LTD lifted its holdings in HCA Healthcare by 22.6% in the third quarter. Longview Partners Guernsey LTD now owns 11,135,155 shares of the company’s stock worth $886,247,000 after purchasing an additional 2,053,701 shares during the period. APG Asset Management N.V. lifted its holdings in HCA Healthcare by 141.4% in the third quarter. APG Asset Management N.V. now owns 3,423,381 shares of the company’s stock worth $272,467,000 after purchasing an additional 2,005,193 shares during the period. Finally, American Century Companies Inc. lifted its holdings in HCA Healthcare by 49.5% in the third quarter. American Century Companies Inc. now owns 2,558,216 shares of the company’s stock worth $203,608,000 after purchasing an additional 847,377 shares during the period. 74.14% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: This report was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://stocknewstimes.com/2018/02/21/hca-healthcare-inc-hca-cmo-sells-3926884-00-in-stock.html.

About HCA Healthcare

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply